HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer.

AuthorsA Alimonti, F Satta, I Pavese, E Burattini, V Zoffoli, A Vecchione
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 14 Issue 5 Pg. 805-6 (May 2003) ISSN: 0923-7534 [Print] England
PMID12702539 (Publication Type: Letter)
Chemical References
  • Bacitracin
  • Irinotecan
  • Neomycin
  • Leucovorin
  • Fluorouracil
  • Camptothecin
Topics
  • Administration, Oral
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
  • Bacitracin (administration & dosage, adverse effects)
  • Camptothecin (administration & dosage, adverse effects, analogs & derivatives)
  • Colorectal Neoplasms (drug therapy)
  • Diarrhea (chemically induced, prevention & control)
  • Fluorouracil (administration & dosage, adverse effects)
  • Humans
  • Irinotecan
  • Leucovorin (administration & dosage, adverse effects)
  • Neomycin (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: